Xinhua Lu | Neurosurgery | Best Researcher Award

Dr. Xinhua Lu | Neurosurgery | Best Researcher Award

Attending Doctor from Foresea Life Insurance Guangzhou General Hospital, China

Xinhua Lu is an emerging biomedical researcher specializing in the molecular mechanisms of nerve regeneration and cell biology. Based in Guangzhou, China, Lu has developed a strong academic and research portfolio through rigorous education and hands-on experience in clinical and laboratory settings. His core focus is centered around the regulatory functions of microRNAs, particularly microRNA-21, in Schwann cell behavior following peripheral nerve injury. Through various research projects, Lu has contributed to the understanding of autophagy, apoptosis, and cellular regeneration pathways, with an emphasis on translational applications in neuroscience and dermatology. His collaborative work has led to co-authorship in several high-impact journals, reflecting a growing reputation in biomedical research. Lu’s research demonstrates interdisciplinary knowledge spanning molecular biology, neurophysiology, and clinical pathology. As a core member of research projects at Zhongshan University, he has played a significant role in advancing discoveries that may lead to novel treatments for nerve damage and degenerative conditions. Known for his dedication, curiosity, and collaborative spirit, Xinhua Lu continues to make meaningful contributions to his field and holds promising potential as a future leader in medical research. His academic integrity and persistence mark him as a valuable member of the scientific community.

Professional Profile

Education

Xinhua Lu has pursued an educational path strongly aligned with clinical and biomedical sciences, beginning with a Bachelor of Science degree in Clinical Medicine from Kunming Medical University, China, completed between September 2008 and July 2013. This foundational education equipped him with core competencies in clinical diagnostics, human anatomy, pharmacology, and patient care. Building on this, Lu further specialized by enrolling in the Master of Science program in Surgery at Zhongshan University in Guangzhou, where he studied from August 2013 to June 2016. During his postgraduate studies, he focused on surgical techniques, clinical interventions, and molecular mechanisms involved in tissue repair. His graduate education laid the groundwork for his research into peripheral nerve injuries and the role of microRNAs in regenerative medicine. Throughout both degree programs, Lu demonstrated strong academic performance and a growing interest in laboratory-based investigations. His thesis work and academic projects were aligned with his current research interests in nerve cell biology, which later transitioned into collaborative and independently led research initiatives. This well-rounded education reflects both theoretical grounding and practical proficiency, qualifying him for research-intensive roles in clinical and academic settings alike.

Professional Experience

Xinhua Lu’s professional experience is marked by his active engagement in biomedical research, particularly focusing on nerve injury and repair. He began his research career as a graduate student at Zhongshan University, where he participated in a project investigating the role of microRNA-21 in Schwann cell behavior post-peripheral nerve injury. This work was not only foundational to his academic development but also instrumental in launching his specialization in neuroregeneration. Between 2016 and 2020, Lu continued his professional trajectory as a core member of a major research project studying the regulatory mechanism of microRNA-21 in Schwann cell autophagy. In this role, he contributed to both experimental design and data analysis, helping elucidate how microRNA-21 modulates cellular processes critical to nerve healing. His involvement in scholarly writing and data interpretation led to multiple co-authored publications in reputable international journals. These experiences positioned Lu as a competent and collaborative researcher capable of handling complex molecular biology projects. In addition to research, he has likely been involved in manuscript preparation and peer communication, showcasing skills essential for academic dissemination. Overall, his professional journey underscores his growing influence in the field and dedication to biomedical advancement.

Research Interest

Xinhua Lu’s primary research interests lie at the intersection of molecular biology and clinical neuroscience, with a specific focus on peripheral nerve injury and repair mechanisms. His fascination with how the body recovers from nerve damage has led him to study Schwann cells, which are critical players in nerve regeneration. A major area of his investigation is the role of microRNA-21 (miR-21) in regulating Schwann cell activity, including its involvement in autophagy, apoptosis inhibition, and proliferation. He is particularly interested in how miR-21 modulates these processes to promote axonal regeneration and functional nerve recovery. In recent years, Lu has expanded his research scope to include broader mechanisms of cell signaling and immune responses, particularly within dermatological and pathological contexts. His work has also explored the cGAS-STING pathway and CD47 signaling, demonstrating a keen interest in understanding immune-mediated responses and cellular aging. His research contributes to both theoretical understanding and the potential development of targeted therapies in neurodegenerative diseases, skin conditions, and injury rehabilitation. By bridging the gap between molecular insight and clinical application, Lu’s research continues to explore complex cellular dynamics with promising translational outcomes.

Research Skills

Xinhua Lu has developed a well-rounded set of research skills that span molecular biology techniques, project coordination, and academic publishing. His laboratory proficiency includes working with cultured Schwann cells, conducting apoptosis and autophagy assays, and utilizing molecular markers to trace cellular changes in response to microRNA modulation. These skills are particularly evident in his work on the mechanisms of miR-21 in nerve regeneration. Lu is adept in experimental design and analysis, often contributing to the validation of hypotheses through controlled in vitro experiments. In addition, he demonstrates competence in interpreting gene expression patterns and cellular signaling pathways. Outside the lab, Lu is skilled in scholarly communication and has co-authored multiple peer-reviewed articles, reflecting his familiarity with the structure, style, and rigor of academic publishing. His technical proficiency also extends to common productivity software such as Microsoft Office and Photoshop, although there is room for advancement in bioinformatics tools and statistical programming. Moreover, his ability to collaborate on multi-year research projects highlights his organizational skills and teamwork. Overall, Lu’s methodological, analytical, and communication abilities position him as a capable biomedical researcher with a solid foundation for continued academic success.

Awards and Honors

While specific awards and honors are not explicitly listed in Xinhua Lu’s profile, his co-authorship on several high-impact, peer-reviewed publications serves as a form of academic recognition in its own right. Publishing in journals such as Brain Pathology, Journal of Cosmetic Dermatology, Journal of Dermatological Science, and RNA Biology reflects the scholarly value and relevance of his research. These publications are typically peer-reviewed by experts and signify rigorous vetting, which in itself is an indicator of research excellence. Being named as a core member in significant research projects at Zhongshan University further underlines his trusted role within the academic research team. This kind of professional trust often correlates with internal academic awards, project-based recognition, or institutional support, even if not explicitly detailed in his CV. Given the caliber of his co-authors and institutions, it is likely that Lu has been involved in competitive grant-funded projects or has received commendation for his academic contributions. Although further documentation of honors such as fellowships, travel grants, or presentation awards would enhance this section, his current achievements provide solid evidence of emerging recognition in the biomedical research community.

Conclusion

Xinhua Lu presents a compelling academic and research profile, characterized by dedication to the study of nerve regeneration and molecular cell biology. With formal education in clinical medicine and surgery, and multiple years of experience in laboratory-based biomedical research, he brings both theoretical knowledge and hands-on expertise to his field. His focused work on microRNA-21 and Schwann cell dynamics demonstrates not only technical ability but also scientific curiosity aimed at solving real-world clinical problems. Through participation in multi-year research projects and peer-reviewed publications, he has proven himself a capable and collaborative scholar. While there is still room to strengthen his portfolio—particularly through greater international exposure, leadership in publications, and diversification of technical skills—Lu’s current achievements position him as a strong candidate for recognition and further academic development. His contributions enrich our understanding of nerve injury mechanisms and open potential pathways for future medical therapies. As he continues his research journey, Xinhua Lu is poised to make a meaningful and lasting impact in biomedical sciences.

Publications Top Notes

  • Title: Elevated CD47 Expression Impairs Elimination of Photoaged Fibroblasts by Macrophages and Serves as a Potential Biomarker for Photoaging

  • Authors: Xu Xinya, Lu Xinhua, Chen Xinling, Yao Amin, Lai Wei

  • Year: 2025

Roberto Crosa | Vascular Neurosurgery | Best Researcher Award

Assoc Prof Dr. Roberto Crosa | Vascular Neurosurgery | Best Researcher Award

Chief of endovasculae Neurosurgeon at Medica Uruguaya CEN, Helwan, Uruguay

Roberto Javier Crosa Erroyzarena is a leading expert in neurovascular research, specializing in endovascular techniques and stroke management. He is skilled in advanced arteriography, thrombectomy procedures, and the treatment of cerebral aneurysms and arteriovenous malformations. Notably, he has pioneered innovative methods like retrograde manometry of cerebral venous sinuses and stenting for pseudotumor cerebri. With extensive experience in endovascular interventions for ischemic stroke, including over 100 thrombectomies, he significantly contributes to the STAR and SITS registries. His involvement in international collaborations and academic presentations further underscores his integration of clinical practice with advanced research, driving progress in neurovascular surgery.

Profile

Education🎓

Roberto Javier Crosa Erroyzarena completed his Doctorate in Medicine at the Faculty of Medicine, University of the Republic (UDELAR) in 2001. He pursued specialization in Neurocirugía at the same institution, graduating in 2007. In the same year, he became a certified Endovascular Neurocirujano in Spain. His commitment to advancing his expertise is reflected in his extensive training across Europe, including internships at the Fondation Adolphe Rothschild in Paris, the Groupe Hospitalier Pitié-Salpêtrière, and the Ospedale Silvestrini in Italy. Further training included advanced minimally invasive techniques at the Global Spine Unit in Germany and neuroendovascular fellowships at prestigious institutions such as the European Neurosurgical Institute in Italy and the University of Siena. His educational journey is marked by a continuous pursuit of cutting-edge knowledge and skills in the field of neurovascular surgery.

Professional Experience 🏢

Roberto Javier Crosa Erroyzarena is a distinguished expert in neurovascular surgery with extensive experience in both clinical and research settings. Since 2011, he has served as a leading figure in neurovascular surgery and endovascular treatments, coordinating for Latin America with STAR (Stroke Thrombectomy and Aneurysm Registry) and MT2020. He has been pivotal in establishing the Centro Angiográfico de Médica Uruguaya, where he has led mechanical thrombectomies since 2014. His role as an independent endovascular neurocirujano at CEDIVA (2007-2014) included pioneering techniques like retrograde manometry of cerebral venous sinuses and venoplasty with stenting. He also led the vascular angiography project at Hospital Maciel and has been a key regional representative for Stroke Lancet. His contributions extend internationally through collaborative roles in Argentina and as a leading figure in various global neurovascular initiatives.

Research Interests 🔬

Roberto Javier Crosa Erroyzarena’s research focuses on advancing neurovascular surgery and endovascular techniques. His primary interests include the development and application of novel methodologies for stroke intervention, particularly mechanical thrombectomy and aneurysm treatment. He has pioneered the use of advanced endovascular techniques in Uruguay, including retrograde manometry of cerebral venous sinuses and venoplasty with stenting for pseudotumor cerebri. Crosa Erroyzarena’s research extends to the optimization of thrombectomy procedures and the treatment of cerebral aneurysms and arteriovenous malformations. As a key figure in the STAR and MT2020 registries, he contributes to international research on stroke management and endovascular interventions. His ongoing projects aim to refine minimally invasive techniques and improve patient outcomes in neurovascular conditions, with a focus on translating innovative approaches into clinical practice.

Award and Honors

Roberto Javier Crosa Erroyzarena has earned recognition for his contributions to neurovascular surgery and endovascular interventions. He is a distinguished member of the STAR (Stroke Thrombectomy and Aneurysm Registry) and MT2020 (Society of Vascular and Interventional Neurology) registries, reflecting his leadership in stroke treatment and research. His pioneering work in Uruguay, including the introduction of mechanical thrombectomy and advanced aneurysm treatments, has been acknowledged through various professional accolades. Crosa Erroyzarena has been honored for his significant contributions to the development of neurovascular techniques and his role in establishing the first SITS (Safe Implementation of Thrombectomy in Stroke) center in Uruguay. His expertise has been recognized internationally through collaborations and prestigious appointments, including his role as a professor at MUSC (Medical University of South Carolina) and his involvement in prominent global neurovascular conferences and courses.

Research Skills

Roberto Javier Crosa Erroyzarena excels in neurovascular research with a focus on endovascular techniques and stroke management. His expertise includes advanced arteriography, thrombectomy procedures, and the treatment of cerebral aneurysms and arteriovenous malformations. Crosa Erroyzarena has pioneered several innovative approaches, such as retrograde manometry of cerebral venous sinuses and stenting for pseudotumor cerebri. He has extensive experience with endovascular interventions for ischemic stroke, having performed over 100 thrombectomies. His research skills are demonstrated through his role in the STAR (Stroke Thrombectomy and Aneurysm Registry) and SITS (Safe Implementation of Thrombectomy in Stroke) registries, where he contributes to data collection and analysis. Additionally, Crosa Erroyzarena’s involvement in international collaborations and his contributions to academic courses and conferences highlight his ability to integrate clinical practice with cutting-edge research, advancing the field of neurovascular surgery.

Publications Top Notes 📚

  1. Outcomes and differences by occluded vessel after endovascular thrombectomy for isolated medium vessel occlusions
    • Authors: Matsukawa, H., Uchida, K., Cunningham, C., Levitt, M.R., Yoshimura, S.
    • Year: 2024
  2. Comparison of balloon guide catheter versus non-balloon guide catheter for mechanical thrombectomy in patients with distal medium vessel occlusion
    • Authors: Orscelik, A., Kallmes, D.F., Bilgin, C., Spiotta, A.M., Brinjikji, W.
    • Year: 2024
  3. Comparative Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Patients with ASPECTS 2-3 vs. 4-5
    • Authors: Orscelik, A., Matsukawa, H., Elawady, S.S., Spiotta, A.M., Kasab, S.A.
    • Year: 2024
  4. Thrombectomy in stroke patients with low Alberta Stroke Program Early Computed Tomography Score: Is modified thrombolysis in cerebral infarction (MTICI) 2C/3 superior to MTICI 2B?
    • Authors: Elawady, S.S., Saway, B.F., Matsukawa, H., Spiotta, A.M., Al Kasab, S.
    • Year: 2024
  5. Comparison between transradial and transfemoral mechanical thrombectomy for ICA and M1 occlusions: Insights from the Stroke Thrombectomy and Aneurysm Registry (STAR)
    • Authors: Silva, M.A., Elawady, S.S., Maier, I., Park, M.S., Starke, R.M.
    • Year: 2024
  6. Predictors of Angiographic Outcome After Failed Thrombectomy for Large Vessel Occlusion: Insights from the Stroke Thrombectomy and Aneurysm Registry
    • Authors: Webb, M., Essibayi, M.A., Al Kasab, S., Spiotta, A., Mascitelli, J.
    • Year: 2023
  7. Risk factors and predictors of intracranial hemorrhage after mechanical thrombectomy in acute ischemic stroke: Insights from the Stroke Thrombectomy and Aneurysm Registry (STAR)
    • Authors: Ironside, N., Chen, C.-J., Chalhoub, R.M., Spiotta, A.M., Park, M.S.
    • Year: 2023
  8. Multicenter investigation of technical and clinical outcomes after thrombectomy for distal vessel occlusion by frontline technique
    • Authors: Alawieh, A.M., Chalhoub, R.M., Al Kasab, S., Grossberg, J.A., Spiotta, A.M.
    • Year: 2023
  9. Mechanical Thrombectomy Global Access for Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study
    • Authors: Asif, K.S., Otite, F.O., Desai, S.M., Le, H.V., Vu, T.T.
    • Year: 2023
  10. Outcomes after endovascular mechanical thrombectomy for low compared to high National Institutes of Health Stroke Scale (NIHSS): A multicenter study
    • Authors: Abecassis, I.J., Almallouhi, E., Chalhoub, R., Spiotta, A.M., Starke, R.M.
    • Year: 2023